申请人:Novartis AG
公开号:US07795253B2
公开(公告)日:2010-09-14
The application relates to novel heterocyclic compounds of the general formula (I) and salts, preferably pharmaceutically acceptable salts, thereof, in which R, R1, R2, R3, Q, m and n have the meanings explained in detail in the description, and * designates an asymmetric carbon atom, a process for their preparation and the use of these compounds as medicaments, in particular as aromatase inhibitors.
该申请涉及一种新型杂环化合物,通式为(I),以及其盐,优选为药学上可接受的盐。其中,R、R1、R2、R3、Q、m和n的含义在说明中详细解释,*表示不对称碳原子,其制备方法以及将这些化合物用作药物,特别是用作芳香化酶抑制剂的用途。